Nike Hits 11-Year Low as Management Guidance Breaks the Recovery Story
Nike shares were hammered on April 1, with a 14% plunge that took the stock down to $45.42 intraday. That $7.44 drop made it the single worst performer in the Dow and the S&P 500 for the day. We are now looking at price levels that haven't been seen since the start of 2015. After losing 28% of its value since the beginning of January, the stock sits 74% below the record highs it touched back in late 2021. This isn't just about a bad quarter. The market is finally waking up to the fact that this isn't a quick fix—the turnaround is going to be much uglier than the company led people to believe.
A "Beat" Without Much Substance
The fiscal third-quarter results showed revenue of $11.28 billion, which is basically flat year-over-year. If you strip out currency shifts, it actually fell about 3%. On the surface, the $0.35 in earnings per share technically beat what the analysts were expecting, but the quality of those earnings was poor. Nike Direct—the business the company spent years telling us was the future—saw revenue fall 7%. Digital sales dropped 9% and store sales were down 5%. Meanwhile, wholesale barely moved, up just 1%. Gross margins were squeezed down to 40.2%, partially due to those North American tariffs. In China, revenue fell 7% to $1.62 billion, marking nearly two years of continuous decline in that region. Even Converse, a supposed staple, saw revenue crater by 35%. It was a beat only because the bar had been lowered so far, and it masked a business that is essentially eroding from the inside.
The Guidance Shock No One Planned For
What really broke the stock was the outlook provided by CEO Elliott Hill and CFO Matt Friend. They’re now forecasting a revenue drop of 2% to 4% for the next quarter. For context, the Street was looking for 2% growth. More significantly, they admitted that this downward trend will likely drag on through the third quarter of 2027. There are even reports suggesting China revenue could plunge 20% in the next quarter alone. Hill described fixing the China business as the company’s "most difficult task." For anyone who was holding the stock on the promise of a recovery by the end of 2026, this was a massive reality check. It wasn't a delay; it was a total reset of the timeline.
Wall Street Piles on the Downgrades
The reaction from the analysts was swift. Bank of America downgraded the stock to Neutral and cut its price target from $73 all the way to $55. They slashed their 2027 earnings estimates to $1.60 and the 2028 estimates to $2.00. JPMorgan also moved to Neutral with a $52 target. A long list of other firms—Goldman, Wells Fargo, Truist—all followed suit, dragging their targets into the $50 range. Even the analysts who have been trying to stay bullish, like the team at Jefferies, are now talking about a recovery that might not show up until 2028. People are basically tearing up their old models and starting from scratch.
A Contested Rebuild, Not a Quick Fix
If you look past the headlines, you can see that Nike isn't just dealing with a standard inventory glut that a few holiday sales can clear out. There are four distinct problems here, and they're all feeding into each other. Brand heat has died down in the high-volume styles that used to drive the business. Wholesale is being used to prop up the numbers while the more profitable Direct business keeps shrinking. Execution in China has fundamentally stalled. And the rest of the brand portfolio, especially Converse, is failing to provide any kind of safety net. Any one of these issues would slow down a recovery. Combined, they completely blow up the "fix is coming" narrative that kept the stock supported above $60.
China is the real sticking point. The competition is proving that the problem isn't just about a soft Chinese economy. Adidas grew its China revenue 13% last year and expects more of the same this year, all while maintaining 51% gross margins. Nike, meanwhile, is losing ground to Adidas and local players like Anta. When your biggest global rival is flourishing in the same market where you are failing, you can't really blame "macro conditions" anymore. It's an execution problem.
Whether Nike is "cheap" here is the wrong question. At 39.5 times trailing earnings, it’s still priced as a premium brand, even though its revenue and margins are moving in the wrong direction. Compare that to companies like Deckers or Lululemon, which trade at much lower multiples—14.5 and 11.3 respectively—and actually saw their stock prices rise today. Nike is now a "show-me" story. They have to stop the bleeding in China, stabilize the Direct business, and prove they can get margins moving back up. Until that actually shows up in the quarterly reports, there is no reason to rush in. Patience is the only sensible move here. Trying to pick a bottom in a stock that is still searching for a floor is a dangerous game.
not investment advice